Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 93-99

  Poen, Joseph C ^a,c   Collins, Helen L ^a   Niederhuber, John E ^a   Oberhelman, Harry A ^a   Vierra, Mark A ^a   Bastidas, Augusto J ^a   Young, Harvey S ^a   Slosberg, Edward A ^a   Jeffrey, Brooke R ^b   Longacre, Teri A ^b   Fisher, George A ^a   Goffinet, Don R ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dose intensity; Pancreas cancer; Protracted venous infusion 5 fluorouracil; Radiation therapy

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BLOOD TOXICITY; BOLUS INJECTION; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0031963938     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00493-8     Document Type: Article

References (30)

1. Allegra, C.J.; Grem, J.L. Pharmacology of cancer chemotherapy. In: DeVita, V.T., Jr., Hellman, S., Rosenberg, S.A., eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott Co; 1997:437-440.
2. Allema J.H., Reinders M.E., van Gulik T.M., Koelemay M.J.W., Van Leeuwen D.J., de Wit L.T., Gouma D.J., Obertop H. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 75:1995;2069-2076.
3. Byfield J.E., Calabro-Jones P., Klisak I., Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int. J. Radiat. Oncol. Biol Phys. 8:1982;1923-1933.
4. Carducci M.A., Abrams R.A., Yeo C.J., Hruban R.H., Zahurak M.L., Cameron J.L., Grochow L.B. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int. J. Radiat. Oncol. Biol Phys. 35:1996;143-150.
5. Douglass H.O. Adjuvant therapy for pancreatic cancer. World J. Surg. 19:1995;270-274.
6. Gallitano A., Fransen H., Martin R.G. Carcinoma of the pancreas. Cancer. 22:1968;939-944.
7. Gamelin E.C., Danquechin-Dorval E.M., Dumesnil Y.F., Malliart P.J., Goudier M.J., Burtin P.C., Delva R.G., Lorthalary A.H., Gesta P.H., Larra F.G. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 77:1996;441-451.
8. Therapy of locally unresectable pancreatic carcinoma A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil . Cancer. 48:1981;1705-1710.
9. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 59:1987;2006-2010.
10. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J. Nat. Cancer Inst. 80:1988;751-755.
11. Green M. Dose-intensive chemotherapy with cytokine support. Sem. Onc. 21:(Suppl.):1994;1-6.
12. Gunderson, L.L.; Willett, C.G. Pancreas and hepatobiliary tract. In: Perez, C.A., Brady, L.W., eds. Principles and Practice of Radiation Oncology. Philadelphia, PA: Lippincott Co; 1992:985-999.
13. Jessup J.M., Steele G., Mayer R.J., Posner M., Busse P., Cady B., Stone M., Jenkins R., Osteen R. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch. Surg. 128:1993;559-564.
14. Kalser M.H., Ellenberg S.S. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120:1985;899-903.
15. Leichman C.G. Prolonged infusion of fluorinated pyrimidines in gastrointestinal malignancies A review of recent clinical trials . Cancer Investigations. 12:1994;166-175.
16. Lokich J.J., Ahlgren J.D., Gullo J.J., Philips J.A., Fryer J.G. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma A Mid-Atlantic Oncology Program study . J. Clin. Oncol. 7:1989;425-432.
17. Mohiuddin M., Regine W.F., Stevens J., Tosato F., Barbot D., Biermann W., Cantor R. Combined intra-operative radiation and peri-operative chemotherapy for unresectable cancers of the pancreas. J. Clin. Oncol. 13:1995;2764-2768.
18. O'Connell M.J., Martenson J.A., Wieand H.S., Krook J.E., Macdonald J.S., Haller D.G., Mayer R.J., Gunderson L.L., Rich T.A. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331:1994;502-507.
19. Perez C.A., Grigsby P.W., Castro-Vita H., Lockett M.A. Carcinoma of the uterine cervix I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy . Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1275-1288.
20. Rich T.A., Lokich J.J., Chaffey J.T. A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy. J. Clin. Oncol. 3:1985;402-406.
21. Rich T.A., Evans D. B. Preoperative combined modality therapy for pancreatic cancer. World J. Surg. 19:1995;264-269.
22. Roldan G.E., Gunderson L.L., Nagorney D.M., Martin J.K., Ilstrup D.M., Holbrook M.A., Kvols L.K., McIlrath D.C. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer. 61:1988;1110-1116.
23. Rothenberg M.L., Moore M.J., Cripps M.C., Andersen J.S., Portenoy R.K., Burris H.A., Green M.R., Tarassoff P.G., Brown T.D., Casper E.S., Storniolo A.M., Von Hoff D.D. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Annals of Oncol. 7:1996;347-353.
24. Seifert P., Baker L.H., Reed M.L., Vaitkevicius V.K. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer. 36:1975;123-128.
25. Shipley W.U., Wood W.C., Tepper J.E., Warshaw A.L., Orlow E.L., Kaufman S.D., Battit G.E., Nardi G.L. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma. Annals of Surg. 200:1984;289-294.
26. Smalley S.R., Kimler B.F., Evans R.G. 5-fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;207-211.
27. Weinerman B., Shah A., Fields A., Cripps I.C., Wilson K., McCormick R., Temple W., Maroun J., Bogoes W., Pater J., Zee B. Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancer. Am. J. Clin. Oncol. 15:1992;518-523.
28. Whittington R., Neuberg D., Tester W.J., Benson A.B., Haller D.G. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma A phase I Eastern Cooperative Oncology Group trial . J. Clin. Oncol. 13:1995;227-232.
29. Wood W.C., Budman D.R., Korzun A.H., Cooper M.R., Younger J., Hart R.D., Moore A., Ellerton J.A., Norton L., Ferree C.R., Ballow A.C., Frei E. III, Henderson I.C. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N. Engl. J. Med. 330:1994;1253-1259.
30. Yeo C.J., Cameron J.L., Lillemore K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., Dooley W.C., Coleman J., Pitt H.A. Pancreaticoduodenectomy for cancer of the head of the pancreas. Annals of Surg. 221:1995;721-733.